Concepedia
Statistics
Publications
6
Citations
212
H-Index
Active since
1992
Affiliations
Boehringer Ingelheim (Germany)(Current)
Pharmalog (Germany)
Takeda (Germany)
Bayer (Germany)
G. Wieckhorst is an author at Boehringer Ingelheim (Germany) specializing in clinical pharmacology, pharmacology, and medicine.
Publications per year
1992–2009
Voglibose (AO-128) Is an Efficient α-Glucosidase Inhibitor and Mobilizes the Endogenous GLP-1 Reserve
Burkhard Göke, H. Fuder, G. Wieckhorst et al. · Digestion · 2009 · 131 citations
Medicine, Endocrinology, Pharmacology +17
Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
Wolfgang Timmer, H Ripke, Peter Kleist et al. · PubMed · 1995 · 22 citations
Medicine, Pharmacology, Pharmacotherapy +13
Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man
A. Ehrlich, H. Fuder, M. Hartmann et al. · European Journal of Clinical Pharmacology · 1996 · 21 citations
Medicine, Pharmacokinetics, Pharmacology +10
The α-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin
H. Fuder, Peter Kleist, M. Birkel et al. · European Journal of Clinical Pharmacology · 1997 · 17 citations
Medicine, Pharmacokinetics, Pharmacology +9
Effect of buffering on pharmacokinetics of ketoprofen enantiomers in man
H. Fuder, S. Stiegler, N Wetzelsberger et al. · British Journal of Clinical Pharmacology · 1997 · 11 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +13
1–5 of 6